Muscular Diseases Clinical Trial
Official title:
Non-invasive Molecular Imaging to Determine Hemoglobin and Collagen Levels in Muscles Before and After Exercise, and Over Time
This study aims to determine hemoglobin and collagen levels in muscles before and after exercise, and over time, using Multispectral Optoacoustic Tomography (MSOT). During MSOT, a transducer is placed on the skin similar to a conventional sonography and instead of sound, energy is supplied to the tissue by means of light flashes. This leads to a constant change of minimal expansions and contractions (thermoelastic expansion) of individual tissue constituents or molecules. The resulting sound waves can then be detected by the same examination unit.
Duchenne muscular dystrophy (DMD) is one of the most common progressive childhood muscle
diseases with an incidence of 1 in 3500 male newborns and is associated primarily with
decreased life expectancy. Pathogenetically, there is a deficiency of dystrophin, a
structural protein of the sarcolemma, which is caused by mutations (usually deletions) of the
dystrophin gene (Xp21.3-p21.2). The result of dystrophin deficiency is a necrosis of muscle
cells that are replaced by connective tissue and adipose tissue. Clinical scores (6-minute
walk test, 6MWT) and MRI studies to characterize the degenerative changes of skeletal muscle
in the early stages are available for the quantitative assessment of the disease progression
as well as therapy effects, the significance of which is controversially discussed. However,
the highly sensitive assessment of gene therapy effects will become increasingly important in
the future. Sensitive, non-invasive methods for the detection of early muscle degeneration
and muscle function in the course are of great clinical and scientific importance.
MSOT has already been demonstrated to be a potential monitoring tool in different diseases.
However, it has not yet been investigated to what extent 1) previous physical activity 2)
different measuring ranges at the muscle, 3) longitudinal measurements and 4) intra- and
interoperative variability influences the measured results. In particular, molecular changes
immediately after the 6-MWT are relevant for studies in patients with DMD.
In this first pilot study, the investigators want to investigate in healthy adults, whether
increased exercise changes the hemoglobin values, whether the collagen content remains
constant and whether repeated measurements at different muscle positions by different
investigators provide consistent results over time. This information is indispensable for
future studies of children with muscular diseases in order to be able to make statements
about disease progression or even therapy response.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00199745 -
Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity
|
Phase 4 | |
Completed |
NCT04115475 -
New Imaging Biomarkers for Muscular Diseases - Multispectral Optoacoustic Imaging in Spinal Muscular Atrophy
|
N/A | |
Completed |
NCT03354767 -
The Role of Ischaemia-reperfusion Injury in the Pathogenesis of Muscle Wasting After Thoracic Aortic Surgery
|
N/A | |
Completed |
NCT03440034 -
Study of Pioglitazone in Sporadic Inclusion Body Myositis
|
Phase 1 | |
Completed |
NCT04838509 -
Diagnoses Associated With Persistent Elevation of Creatine Kinase
|
||
Completed |
NCT03406780 -
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
|
Phase 2 | |
Completed |
NCT01826487 -
Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
|
Phase 3 | |
Terminated |
NCT02090959 -
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
|
Phase 3 | |
Recruiting |
NCT05126758 -
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
|
Phase 3 | |
Recruiting |
NCT05183152 -
Non-invasive BCI-controlled Assistive Devices
|
N/A | |
Completed |
NCT03179631 -
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
|
Phase 3 | |
Terminated |
NCT02829814 -
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
|
Phase 3 | |
Recruiting |
NCT06226376 -
Mollii Suit and Fibromyalgia (EXOFIB 2)
|
N/A | |
Completed |
NCT03250988 -
Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility
|
||
Completed |
NCT03209960 -
Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity
|
||
Completed |
NCT03211390 -
Using Telemedicine to Improve Spasticity Diagnosis Rates
|
||
Completed |
NCT00609063 -
The Effect of Statin Medications on Muscle Performance (The STOMP Study)
|
N/A | |
Terminated |
NCT00240981 -
TOM: Testosterone in Older Men With Sarcopenia
|
Phase 4 | |
Completed |
NCT03268421 -
Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia
|
N/A | |
Completed |
NCT05730842 -
Absorption, Metabolism, Excretion and Absolute Bioavailability of EDG-5506 in Healthy Volunteers
|
Phase 1 |